.jpg)
.png)
The following are some basic thoughts and information on guidelines based on my understanding.
Article By:
Oklahoma University Health Sciences Center
Oklahoma City, OK
Diplomate, American Board of Clinical Lipidology
Greetings! I was honored and excited to be nominated as the President of the Southwest Lipid Association (SWLA) at the National Lipid Association’s (NLA) Annual Scientific Sessions in May 2014. As we acknowledge the team that have been at the executive level and performed with high energy, we would like to tap into their continued support. This year, we plan to move forward with exuberance in creating new strategies for our continued growth.
Article By:
Clinical Professor of Medicine, University of Arizona
Vice President, Scottsdale Cardiovascular Center
Scottsdale, AZ
Diplomate, American Board of Clinical Lipidology
“Knowing is not enough; we must apply. Willing is not enough; we must do.” – Johann Wolfgang von Goethe
Being a part of the National Lipid Association is about more than just raising awareness about lipid disorders — it’s about effecting change within our communities and across the country.
Article By:
Professor of Medicine, Emory University
Atlanta, GA
Director, Lipid Clinic and Cardiovascular Risk Reduction Program
Diplomate, American Board of Clinical Lipidology
The NLA Recommendations for Patient-Centered Management of Dyslipidemia was recently published in the Journal of Clinical Lipidology. As you know, these Recommendations are a tool for clinicians who treat patients with dyslipidemia — and they should serve as guidance for treatment. To ensure that the NLA Recommendations are successful and reach as many clinicians as possible, we need your help and involvement!
By Carl E. Orringer
A 55-year-old South Asian Indian physician comes to you for management recommendations for primary prevention of atherosclerotic cardiovascular disease (ASCVD). He has no current cardiovascular symptoms.
He has an eight-year history of well-controlled arterial hypertension, for which he has been treated with lisinopril 10 mg daily. He is a nonsmoker, has no history of diabetes and has never taken treatment for a lipid disorder. His father had an MI at age 52.
From Cardiovascular Business:
By Candace Stuart
The National Lipid Association (NLA) published recommendations that are designed to help fill the gaps in the 2013 cholesterol guidelines jointly released by two cardiology associations. The report aligns with some aspects of the guidelines but diverges on cholesterol targets.
September 24 is Familial Hypercholesterolemia (FH) Awareness Day. It was initiated by the FH Foundation as part of their mission to raise awareness of FH in the public. As a supporter of this initiative, the National Lipid Association (NLA) and the Foundation of the NLA would like to help bring awareness to this important day and support the FH Foundation’s efforts. Please click here for more information on this important day and how you can spread the word.
Expert Panel Re-affirms the Importance of Setting Cholesterol Goals for the Prevention of Heart Attack and Stroke
Increasing obesity is one the most important healthcare problems in United States and has become a major focus of recent government initiatives to improve the health of the country.
The serious effects of obesity are even greater in Indians and other South Asians especially in the case of obesity around the waist. Although, Body Mass index (BMI) is the commonest measure of obesity we now know that a more dangerous type of obesity is “Abdominal Obesity”. “Abdominal”, sometimes called “central”, obesity which is best measured by waist size.
Recent survey shows need for triglyceride testing and improved reporting by health care providers
JACKSONVILLE, Fla. (September 2014) — In response to recent survey findings, the National Lipid Association (NLA) announces a nationwide educational campaign to raise awareness within target consumer audiences. Their goal is to encourage patient education and drive discussions around lipid management and the resulting consequences for high cholesterol and triglycerides.